Published on August 7, 2019
What new therapies are in the pipeline for chronic lymphocytic leukemia (CLL)? What is the side effect profile for novel agents? CLL specialist and dedicated researcher Dr. Nicole Lamanna, from Columbia University Medical Center, shares insight on the latest treatment developments and progress in clinical trials. With a hopeful outlook, Dr. Lamanna describes new therapies under investigation, recent drug approvals and how to sequence novel agents to reduce toxicities. Watch now to hear expert updates on CLL therapy.
This program is sponsored by AbbVie, Inc, Genentech, Inc and Adaptive Biotechnologies. These organizations have no editorial control. It is produced by Patient Power in partnership with The Leukemia & Lymphoma Society (LLS), CLL Society and OHC (Oncology Hematology Care). Patient Power is solely responsible for program content.
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.